OBJECTIVE: To evaluate the effect of bisphenol-A (BPA), a xenoestrogen endocrine disruptor, on endometrial P receptor (PR) expression in nonhuman primates and human cells. DESIGN: Controlled trial in primates. SETTING: University. ANIMAL(S): African green monkeys. INTERVENTION(S): After oophorectomy, BPA (50 μg/kg/d), E(2), both, or vehicle control were administered. Estradiol and BPA were used in Ishikawa cells. MAIN OUTCOME MEASURE(S): Progesterone receptor expression using immunohistochemistry and quantitative polymerase chain reaction. RESULT(S): Progesterone receptor expression was increased in E(2)-treated primates compared with controls. Exposure to the combination of E(2) and BPA resulted in decreased PR expression compared with E(2) exposure alone. In Ishikawa cells treated with E(2), PR expression increased 5.1-fold; however, when Ishikawa cells were simultaneously treated with E(2) and BPA, PR expression was decreased to 0.6-fold that of cells treated with E(2) alone. CONCLUSION(S): Bisphenol-A alone functions as a weak estrogen. However, when administered with E(2), BPA diminishes E(2)-induced PR expression. The estrogen-like effect of BPA reported in exposed humans may be mediated by PR blockade and a resultant decrease in the estrogen inhibition normally imparted by P. Diminished PR expression may underlie previous reports linking BPA exposure to endometrial dysfunction in humans.
OBJECTIVE: To evaluate the effect of bisphenol-A (BPA), a xenoestrogen endocrine disruptor, on endometrial P receptor (PR) expression in nonhuman primates and human cells. DESIGN: Controlled trial in primates. SETTING: University. ANIMAL(S): African green monkeys. INTERVENTION(S): After oophorectomy, BPA (50 μg/kg/d), E(2), both, or vehicle control were administered. Estradiol and BPA were used in Ishikawa cells. MAIN OUTCOME MEASURE(S): Progesterone receptor expression using immunohistochemistry and quantitative polymerase chain reaction. RESULT(S): Progesterone receptor expression was increased in E(2)-treated primates compared with controls. Exposure to the combination of E(2) and BPA resulted in decreased PR expression compared with E(2) exposure alone. In Ishikawa cells treated with E(2), PR expression increased 5.1-fold; however, when Ishikawa cells were simultaneously treated with E(2) and BPA, PR expression was decreased to 0.6-fold that of cells treated with E(2) alone. CONCLUSION(S): Bisphenol-A alone functions as a weak estrogen. However, when administered with E(2), BPA diminishes E(2)-induced PR expression. The estrogen-like effect of BPA reported in exposed humans may be mediated by PR blockade and a resultant decrease in the estrogen inhibition normally imparted by P. Diminished PR expression may underlie previous reports linking BPA exposure to endometrial dysfunction in humans.
Authors: Patricia A Hunt; Kara E Koehler; Martha Susiarjo; Craig A Hodges; Arlene Ilagan; Robert C Voigt; Sally Thomas; Brian F Thomas; Terry J Hassold Journal: Curr Biol Date: 2003-04-01 Impact factor: 10.834
Authors: L Aghajanova; K Tatsumi; J A Horcajadas; A M Zamah; F J Esteban; C N Herndon; M Conti; L C Giudice Journal: Biol Reprod Date: 2010-09-23 Impact factor: 4.285
Authors: B A Lessey; A J Castelbaum; S W Sawin; C A Buck; R Schinnar; W Bilker; B L Strom Journal: J Clin Endocrinol Metab Date: 1994-08 Impact factor: 5.958
Authors: Catha Fischer; Ramanaiah Mamillapalli; Laura G Goetz; Elisa Jorgenson; Ysabel Ilagan; Hugh S Taylor Journal: Horm Cancer Date: 2016-02-24 Impact factor: 3.869
Authors: Ruth B Lathi; Cara A Liebert; Kathleen F Brookfield; Julia A Taylor; Frederick S vom Saal; Victor Y Fujimoto; Valerie L Baker Journal: Fertil Steril Date: 2014-04-18 Impact factor: 7.329
Authors: Kristen Upson; Sheela Sathyanarayana; Anneclaire J De Roos; Holger M Koch; Delia Scholes; Victoria L Holt Journal: Hum Reprod Date: 2014-09-09 Impact factor: 6.918